A Study to Evaluate the Effect of Genotype on LY2216684
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The study will evaluate how genetic profiles respond to LY2216684 and the effect of Quinidine
on the pharmacokinetics (PK) of LY2216684 in a specific genetic profile. Side effects will be
documented.